# Medeligo vs NephRef

The clearest difference is in-app purchases: NephRef at none against Medeligo's 1. NephRef also leads on ads (none vs shown) and update cadence (every 10 days vs every 5 months). Medeligo's advantage is ratings volume (9 vs 1). On price, rating and device support there is nothing between them.

Both are free to download. Medeligo sells 1 in-app purchase, starting at $24.99 per year. NephRef asks for nothing beyond the download.

On the App Store both sit at effectively the same score — 5.0 for Medeligo against 5.0 for NephRef. That said, the two scores are not equally well evidenced: Medeligo has 9 ratings behind it against 1, so its average is the more settled of the two.

Medeligo ships an update every 5 months, NephRef every 10 days. The most recent releases landed on October 5, 2026 and September 18, 2026 respectively.

## The numbers

| Metric | Medeligo | NephRef |
| --- | --- | --- |
| Price | Free | Free |
| Rating | [5.0 (9 ratings)](https://appshunter.io/ios/app/medeligo/id1000247107/reviews) | [5.0 (1 ratings)](https://appshunter.io/ios/app/nephref/id1486749987/reviews) |
| Number of ratings | **9** | 1 |
| Positive reviews | 100.0% of reviews | — |
| In-app purchases | Yes | **No** |
| Ads | Yes | **No** |
| Update frequency | Every 5 months | **Every 10 days** |
| Monetization | Free with in-app purchases | **Free** |
| Size | 4 MB | 44 MB |
| Requires iOS | 14.0 | **11.0** |
| Devices | iPhone, iPod | **iPhone, iPad, iPod** |
| Age rating | 17+ | 12+ |
| Developer | [LiveMed Media Ltd.](https://appshunter.io/developer/979061491) | [Media Foundations LLC](https://appshunter.io/developer/589717539) |

## What reviewers say

### Medeligo

[App page](https://appshunter.io/ios/app/medeligo/id1000247107)

Access the latest oncology research and treatment information instantly. This app features AI-powered search, real-time updates from trusted sources, and covers over 2,000 cancer types. Quickly find literature, videos, and images to prepare for patient care and answer complex questions.

**Highlights:** AI-powered search, Real-time oncology information, Covers 2,000+ cancer types, Access to literature, videos, and images, Trusted medical journal searches, Save, share, and print articles

**In-app purchases (1)**

| Purchase | Price | Billing |
| --- | --- | --- |
| All Access (1 year) | $24.99 | per year |


### NephRef

[App page](https://appshunter.io/ios/app/nephref/id1486749987)

This medical reference tool aids physicians and advanced practitioners in managing patients with kidney disease. It provides quick access to educational resources and guidance on patient referral, urgency, and interval management.

**Highlights:** Kidney disease patient care guidance, Referral management, Urgency assessment, Interval management, Educational resources access

**Features:** macOS Compatibility

**In-app purchases:** none


## Frequently asked questions

### Is Medeligo free?

Medeligo is free to download, with in-app purchases available.

### Is NephRef free?

NephRef is free to download, with no in-app purchases.

### Which has better reviews, Medeligo or NephRef?

Medeligo and NephRef are both rated 5.0 out of 5 on the App Store, from 9 and 1 ratings respectively.

### Do Medeligo or NephRef have ads?

Medeligo shows ads; NephRef does not.

### Which is updated more often, Medeligo or NephRef?

Medeligo ships an update every 5 months, and NephRef every 10 days. Most recently, Medeligo was updated on October 5, 2026 and NephRef on September 18, 2026.

---

*Compared by [AppsHunter](https://appshunter.io/) from daily US App Store data. Review summaries are generated from verbatim App Store reviews.*